FDA
approval
· 2023-04-11
FDA Approved: AMLODIPINE AND VALSARTAN — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
The FDA approved a supplemental application from Mylan Pharmaceuticals for a generic amlodipine/valsartan combination product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMLODIPINE AND VALSARTAN (AMLODIPINE AND VALSARTAN)